1 / 7

Science at the FDA: Update for the Science Board

Science at the FDA: Update for the Science Board. Jesse L. Goodman, MD, MPH Chief Scientist and Deputy Commissioner for Science and Public Health November 15, 2010. Updates. Thanks to “retiring” members and Chair! NIH/FDA Leadership Council Activities

lester
Download Presentation

Science at the FDA: Update for the Science Board

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Science at the FDA: Update for the Science Board Jesse L. Goodman, MD, MPH Chief Scientist and Deputy Commissioner for Science and Public Health November 15, 2010

  2. Updates • Thanks to “retiring” members and Chair! • NIH/FDA Leadership Council Activities • September 28, 2010 - NIH/FDA Joint Regulatory Science Awards • Leadership Council Update • Critical Path Grant Awards on TB – Sept. 30 • FDA Clinical Investigator Course – Nov. 8-10 • Chemical and Environmental Science Council • New FDA wide Scientific Professional Development Calendar with online links and including relevant NIH events

  3. Sample: Today’s FDA Scientific Development Calendar • Time: 12:00 pm – 1:00 pmTitle: Challenges in Developing Process Analytical Technologies for Antibody Quality AttributesSpeaker: Erik Read, Ph.D.Sponsored by: CDER, OBP, Division of Monoclonal AntibodiesLocation: NIH Building 29B, Conference Room CPoint of Contact: Dr. Gerald Feldman; Gerald.feldman@fda.hhs.gov • Time:  1:00 pm – 2:00 pm • Title: Contact Lens Related Eye Infections: How We Got Here, Where We are Going • Speaker:  Megan Shoff, PhD • Sponsored by:  Office of Science and Engineering Laboratories, CDRH • Location: Building 66, Room G514 • Point of Contact: Dr. Joyce Whang, Joyce.Whang@fda.hhs.gov • Moving Forward in the Efficient Management and Use of Core Facilities - Day 1Monday, November 15, 2010, 8:30 AM • TRACO: RNAi and Lung CancerMonday, November 15, 2010, 4:00 PM

  4. Updates (cont.) • 2008 Fellows graduation and follow-up statistics • Key figure: 38/48 (~80%) retained at FDA • Continuing development of major partnerships with academic institutions • October 6, 2010 - Release of FDA White Paper: Advancing Regulatory Science for Public Health and Commissioner’s National Press Club event • PACES/CER progress – presentation later • Medical Countermeasures progress – presentation later • Science and Innovation Senior Advisory Council (SISAC) • Leadership retreat, development of draft strategic priorities

  5. SISAC: Draft Strategic Scientific Priority Areas • Transforming development of medical countermeasures against threats to US and global health and security • Innovation in product development and evaluation: biomarkers, personalized medicine and effective clinical studies • Harnessing diverse data through information sciences to improve health outcomes • Modernizing toxicology and risk assessment to better predict safety

  6. Draft Strategic Scientific Priority Areas (cont.) • Supporting new approaches to improve product manufacturing and quality • Protecting the food supply • Ensuring FDA’s readiness to evaluate new and emerging technologies • Advancing behavioral science to empower informed decision making and use of products by professionals and consumers

  7. Not intended to replace Center plans but to provide overarching framework, priorities, ensure coordination and drive agency-wide and collaborative projects and shared resource use Being refined by Senior Science Council and engaging all Centers and major cross-cutting projects and outcomes being defined in each priority area as strategic plan is developed Input sought now and in future Thanks! Going forward

More Related